Kyryl completed his PhD studies in Warren’s lab in 2016 developing Luna’s core nanomaterial diagnostic technologies. After finishing his PhD, Kyryl has been overseeing business operations of Luna Diagnostic’s sister company Luna Nanotech. Luna Nanotech provides a range of nanomaterial and nucleic acid purification solutions for the biotechnology and biomedical research sectors. During Covid-19 pandemic Luna Nanotech supplied reagents and components for SARS-CoV-2 diagnostics to Canadian, USA, and European clients. Over the last 2 years Luna Nanotech has been steadily growing its products offering, increasing its customer base in Canada, as well as growing its international distribution network. Kyryl is now focusing on leading the development and growth of Luna Diagnostics and its core point-of-care diagnostic technology.

• 

  FOUNDER, CEO in Luna Diagnostics

  Personalized medicine starts with personalized diagnostics.